vs

Side-by-side financial comparison of Fluent, Inc. (FLNT) and Health Catalyst, Inc. (HCAT). Click either name above to swap in a different company.

Health Catalyst, Inc. is the larger business by last-quarter revenue ($74.7M vs $61.8M, roughly 1.2× Fluent, Inc.). Fluent, Inc. runs the higher net margin — -6.7% vs -121.9%, a 115.2% gap on every dollar of revenue. On growth, Fluent, Inc. posted the faster year-over-year revenue change (-5.5% vs -6.2%). Over the past eight quarters, Health Catalyst, Inc.'s revenue compounded faster (-0.0% CAGR vs -3.2%).

THG Fluently, formerly Language Connect, is a translation and language localisation service provided by THG Ingenuity. It provides a range of language services, including translation, interpreting, localisation, voice-overs, transcription, and multilingual search engine optimization.

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Fir...

FLNT vs HCAT — Head-to-Head

Bigger by revenue
HCAT
HCAT
1.2× larger
HCAT
$74.7M
$61.8M
FLNT
Growing faster (revenue YoY)
FLNT
FLNT
+0.7% gap
FLNT
-5.5%
-6.2%
HCAT
Higher net margin
FLNT
FLNT
115.2% more per $
FLNT
-6.7%
-121.9%
HCAT
Faster 2-yr revenue CAGR
HCAT
HCAT
Annualised
HCAT
-0.0%
-3.2%
FLNT

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FLNT
FLNT
HCAT
HCAT
Revenue
$61.8M
$74.7M
Net Profit
$-4.1M
$-91.0M
Gross Margin
Operating Margin
0.3%
-115.3%
Net Margin
-6.7%
-121.9%
Revenue YoY
-5.5%
-6.2%
Net Profit YoY
-20.1%
-340.3%
EPS (diluted)
$-0.09
$-1.29

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLNT
FLNT
HCAT
HCAT
Q4 25
$61.8M
$74.7M
Q3 25
$47.0M
$76.3M
Q2 25
$44.7M
$80.7M
Q1 25
$55.2M
$79.4M
Q4 24
$65.4M
$79.6M
Q3 24
$64.5M
$76.4M
Q2 24
$58.7M
$75.9M
Q1 24
$66.0M
$74.7M
Net Profit
FLNT
FLNT
HCAT
HCAT
Q4 25
$-4.1M
$-91.0M
Q3 25
$-7.6M
$-22.2M
Q2 25
$-7.2M
$-41.0M
Q1 25
$-8.3M
$-23.7M
Q4 24
$-3.4M
$-20.7M
Q3 24
$-7.9M
$-14.7M
Q2 24
$-11.6M
$-13.5M
Q1 24
$-6.3M
$-20.6M
Gross Margin
FLNT
FLNT
HCAT
HCAT
Q4 25
Q3 25
52.6%
Q2 25
Q1 25
Q4 24
Q3 24
47.5%
Q2 24
Q1 24
Operating Margin
FLNT
FLNT
HCAT
HCAT
Q4 25
0.3%
-115.3%
Q3 25
-13.4%
-22.9%
Q2 25
-15.9%
-46.0%
Q1 25
-12.8%
-25.4%
Q4 24
-8.3%
-22.0%
Q3 24
-6.0%
-17.9%
Q2 24
-17.7%
-20.8%
Q1 24
-6.0%
-30.5%
Net Margin
FLNT
FLNT
HCAT
HCAT
Q4 25
-6.7%
-121.9%
Q3 25
-16.1%
-29.1%
Q2 25
-16.2%
-50.8%
Q1 25
-15.0%
-29.9%
Q4 24
-5.2%
-26.0%
Q3 24
-12.3%
-19.3%
Q2 24
-19.8%
-17.8%
Q1 24
-9.5%
-27.6%
EPS (diluted)
FLNT
FLNT
HCAT
HCAT
Q4 25
$-0.09
$-1.29
Q3 25
$-0.27
$-0.32
Q2 25
$-0.30
$-0.59
Q1 25
$-0.39
$-0.35
Q4 24
$-0.12
$-0.33
Q3 24
$-0.48
$-0.24
Q2 24
$-0.75
$-0.23
Q1 24
$-0.45
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLNT
FLNT
HCAT
HCAT
Cash + ST InvestmentsLiquidity on hand
$12.9M
$95.7M
Total DebtLower is stronger
$34.6M
$153.3M
Stockholders' EquityBook value
$18.2M
$245.8M
Total Assets
$89.1M
$502.6M
Debt / EquityLower = less leverage
1.90×
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLNT
FLNT
HCAT
HCAT
Q4 25
$12.9M
$95.7M
Q3 25
$9.2M
$91.5M
Q2 25
$4.9M
$97.3M
Q1 25
$4.8M
$342.0M
Q4 24
$9.4M
$392.0M
Q3 24
$6.6M
$387.3M
Q2 24
$5.0M
$308.3M
Q1 24
$11.7M
$327.8M
Total Debt
FLNT
FLNT
HCAT
HCAT
Q4 25
$34.6M
$153.3M
Q3 25
$26.0M
$153.1M
Q2 25
$23.2M
$153.0M
Q1 25
$25.6M
$382.9M
Q4 24
$35.6M
$382.4M
Q3 24
$37.9M
$345.0M
Q2 24
$33.3M
Q1 24
$31.0M
Stockholders' Equity
FLNT
FLNT
HCAT
HCAT
Q4 25
$18.2M
$245.8M
Q3 25
$21.6M
$331.9M
Q2 25
$19.1M
$347.5M
Q1 25
$22.0M
$376.8M
Q4 24
$25.0M
$365.2M
Q3 24
$20.0M
$355.0M
Q2 24
$27.5M
$357.0M
Q1 24
$28.7M
$357.2M
Total Assets
FLNT
FLNT
HCAT
HCAT
Q4 25
$89.1M
$502.6M
Q3 25
$76.1M
$587.1M
Q2 25
$74.5M
$616.2M
Q1 25
$77.5M
$891.5M
Q4 24
$93.6M
$858.9M
Q3 24
$77.5M
$813.0M
Q2 24
$98.5M
$691.7M
Q1 24
$103.6M
$695.1M
Debt / Equity
FLNT
FLNT
HCAT
HCAT
Q4 25
1.90×
0.62×
Q3 25
1.21×
0.46×
Q2 25
1.21×
0.44×
Q1 25
1.16×
1.02×
Q4 24
1.43×
1.05×
Q3 24
1.90×
0.97×
Q2 24
1.21×
Q1 24
1.08×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLNT
FLNT
HCAT
HCAT
Operating Cash FlowLast quarter
$2.8M
$9.9M
Free Cash FlowOCF − Capex
$9.6M
FCF MarginFCF / Revenue
12.9%
Capex IntensityCapex / Revenue
0.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-697.0K

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLNT
FLNT
HCAT
HCAT
Q4 25
$2.8M
$9.9M
Q3 25
$-7.3M
$-464.0K
Q2 25
$935.0K
$-9.0M
Q1 25
$2.1M
$280.0K
Q4 24
$-2.1M
$-3.5M
Q3 24
$1.2M
$6.2M
Q2 24
$-13.1M
$1.6M
Q1 24
$-132.0K
$10.3M
Free Cash Flow
FLNT
FLNT
HCAT
HCAT
Q4 25
$9.6M
Q3 25
$-7.3M
$-719.0K
Q2 25
$-9.2M
Q1 25
$-390.0K
Q4 24
$-3.9M
Q3 24
$1.2M
$5.5M
Q2 24
$1.3M
Q1 24
$10.1M
FCF Margin
FLNT
FLNT
HCAT
HCAT
Q4 25
12.9%
Q3 25
-15.6%
-0.9%
Q2 25
-11.4%
Q1 25
-0.5%
Q4 24
-4.9%
Q3 24
1.9%
7.2%
Q2 24
1.7%
Q1 24
13.5%
Capex Intensity
FLNT
FLNT
HCAT
HCAT
Q4 25
0.4%
Q3 25
0.0%
0.3%
Q2 25
0.3%
Q1 25
0.8%
Q4 24
0.5%
Q3 24
0.0%
0.9%
Q2 24
0.4%
Q1 24
0.3%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLNT
FLNT

Commerce Media Solutions$34.7M56%
Owned And Operated$21.3M34%
Call Solutions$3.8M6%
Ad Parlor$2.0M3%

HCAT
HCAT

Recurring Technology$51.9M69%
Professional Services$22.8M31%

Related Comparisons